Failure to receive such approval may well have an effect on our capability to produce revenue from this item line. We have previously been engaged in a lawsuit with a former distributor of our goods whilst we have settled the lawsuit, we are currently engaged in a formal arbitration process intended to resolve claims of alleged breach of settlement. In addition, to execute our growth strategy, we will have to attract and retain highly qualified personnel. New members of management need to have substantial market expertise when they join us or engage in important training which, in numerous cases, calls for significant time ahead of they realize full productivity. If we fail to attract, train, retain, and motivate our key personnel, our business and development prospects could be adversely affected.
Its cash, including restricted money on hand, at December 31, 2019 was $1,717,464. While we intend to seek FDA and Wellness Canada approval for some of our Anvirzel® goods, there can be no assurance that such approval will ever be granted.
Nerium International Age Defying Day & Evening Cream Set 30ml
Our new solution development calls for us to investigate and evaluate several alternatives, as properly as strategy the design and manufacture of these options chosen for additional improvement. Our improvement efforts could be adversely impacted by solution development delays, changes in operating systems and modifications in industry standards. The manufacturing of new products involves integrating styles and processes, coordinating with suppliers for components and elements and managing manufacturing capacities to accommodate forecasted demand. If we are not profitable in meeting these specifications, this could adversely impact our capacity to introduce new products on a timely basis. Our sales model is heavily dependent on securing a substantial quantity of independent sales representatives.
Other revenue comprising rental earnings derived from leasing a portion of the farm acreage was capitalized to the 2019 production of oleander powder. It reported sales of $2,976,035 and a net extensive loss attributable to controlling interest for the year of $four,967,307. It created a considerable further investment of $2,171,552 in inventory, it spent $83,198 on property, plant and equipment, and it committed $190,229 to further patent and trademark expenditures.
Genus Nerium
We do not have a massive sales force, and failure to recruit an sufficient quantity of independent sales representatives could have an adverse impact on our small business and our financial position. The Organization has its product formulations manufactured in the U.S. by 4 various providers. We may want to discover more or much more extensive manufacturing capacity in order to enhance our sales.
At December 31, 2017, nerium; my company, determined that it was no longer able to physical exercise significant influence over Biova, and at that point in time, it adopted the price approach to report its residual interest in Biova. Thereafter, Nerium opted to forgo money contributions needed to maintain its investment percentage which, as a result, declined to 15.53% as of December 31, 2019. Other revenue for the year ended December 31, 2019 totaled $19,862 compared to $141,674 for the year ended December 31, 2018.